gvtcx

Supply of testing for SARS-CoV-2 antibody test

Nhs Blood and Transplant Published 6 Apr 2021 Contracts Finder

key details

Value£105,000
Statuscomplete
Category (CPV) 85111810
Deadline29 Mar 2021
Contract start31 Mar 2021
Contract end31 Mar 2022
Procedurelimited
SME suitableNo
OCIDocds-b5fd17-cc18a175-b587-49ff-b9ab-7c4e58f6d47c

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £105,000.

SupplierValueDateStatus
Public Health England £380,000 30 Mar 2021 active
Public Health England £275,000 · active

description

NHS Blood and Transplant (NHSBT) are leading the Convalescent Plasma programme to explore the efficacy of donated plasma in the treatment of severe COVID-19 disease. Plasma will be donated by individuals who have recovered from COVID-19 disease and those plasma units with a sufficiently high level of antibody will be used as a treatment. Public Health England (PHE) will be carrying out Testing on the Materials on behalf of NHSBT. This will involve a SARS-CoV-2 IgG antibody Testing service (using a CE-marked assay) to NHSBT to enable the identification of convalescent plasma donations with sufficient level of antibody.

Duration extended from 31st March 2021 to 31st March 2022 to allow for testing of c. 7000 research samples from the RECOVERY clinical trial.

Additional information: Total value of original VEAT notice and this Modification notice is £380,000

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
6 Apr 2021 Award (award) · 648b6763-cc31-421e-9863-55082ab81c6c-426144

more from Nhs Blood and Transplant

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.